{"id":159076,"date":"2026-07-20T10:19:03","date_gmt":"2026-07-20T10:19:03","guid":{"rendered":"https:\/\/pabau.com\/?p=159076"},"modified":"2026-08-13T12:11:29","modified_gmt":"2026-08-13T12:11:29","slug":"hcpcs-code-j2997","status":"publish","type":"post","link":"https:\/\/pabau.com\/es\/procedure-codes\/hcpcs-code-j2997\/","title":{"rendered":"HCPCS Code J2997: Alteplase billing, coverage, and reimbursement"},"content":{"rendered":"\n<script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"MedicalWebPage\",\"headline\":\"HCPCS Code J2997: Alteplase billing, coverage, and reimbursement guide\",\"description\":\"HCPCS Code J2997 covers alteplase (tPA) injection billing at 1 mg per unit. Learn Medicare coverage, ASP reimbursement, required modifiers, ICD-10 diagnosis codes, and denial prevention.\",\"url\":\"https:\/\/pabau.com\/procedure-codes\/hcpcs-code-j2997\/\",\"audience\":{\"@type\":\"MedicalAudience\",\"audienceType\":\"Clinician\"},\"reviewedBy\":{\"@type\":\"Person\",\"name\":\"Dr Vanja Kitanova\",\"jobTitle\":\"Medical Reviewer\",\"affiliation\":{\"@type\":\"Organization\",\"name\":\"Pabau\"},\"knowsAbout\":[\"Medical Coding\",\"Clinical Documentation\",\"Healthcare Billing\",\"Clinical Safety\"],\"sameAs\":\"https:\/\/pabau.com\/blog\/author\/vanja\/\"},\"datePublished\":\"2026-07-20\",\"dateModified\":\"2026-07-20\"}<\/script>\n\n\n        <div id=\"key_takeaways\">\n            <div class=\"header\">\n                                    <img decoding=\"async\" src=\"https:\/\/pabau.com\/wp-content\/uploads\/2025\/12\/Key-Takeaways-Icon.svg\" alt=\"Key Takeaways\" height=\"42\" width=\"42\">\n                                <h3>Key Takeaways<\/h3>\n            <\/div>\n            <div class=\"list\">\n                                                            <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>HCPCS Code J2997 is the Level II drug code for injection, alteplase recombinant, billed per 1 mg administered<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>J2997 is covered under Medicare Part B and reimbursed at ASP + 6% in the non-facility setting; rates change quarterly<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>NDC reporting is required on every J2997 claim submitted to Medicare, using the 5-4-2 format with the N4 qualifier<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>Practice management software like Pabau helps IV therapy and hospital outpatient billers track drug units, modifiers, and NDC fields to reduce J2997 denials<\/p>\n                        <\/div>\n                                                <\/div>\n        <\/div>\n    \n\n\n<p class=\"wp-block-paragraph\">HCPCS Code J2997 covers injection, alteplase recombinant, per 1 mg, and it sits in the J-series of <a href=\"https:\/\/www.cms.gov\/medicare\/coding-billing\/healthcare-common-procedure-system\" target=\"_blank\" rel=\"nofollow noopener\">HCPCS Level II codes<\/a> maintained by the Centers for Medicare and Medicaid Services (CMS). Getting the units, modifiers, and diagnosis codes right on every claim matters.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This guide covers everything billers and coders need to submit accurate <a href=\"https:\/\/pabau.com\/industry\/iv-therapy-emr-software\/\">IV therapy EMR software<\/a>-supported claims for J2997, including Medicare coverage, reimbursement methodology, step-by-step billing instructions, required modifiers, and the most common denial triggers.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">J2997 code description and drug details<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">HCPCS Code J2997 describes alteplase recombinant, a tissue plasminogen activator (tPA) used to dissolve blood clots in acute clinical emergencies. The billing unit is per 1 mg, which means the number of units reported on the claim must equal the exact milligrams administered to the patient.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">J2997 quick reference table<\/h3>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Field<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Detail<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">HCPCS Code<\/td>\n<td style=\"padding:12px 16px;color:#374151\">J2997<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Official descriptor<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Injection, alteplase recombinant, 1 mg<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Drug name(s)<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Alteplase (Activase); manufactured by Genentech \/ Roche<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Drug class<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Thrombolytic agent (fibrinolytic \/ tPA)<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Billing unit<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Per 1 mg administered<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Code series<\/td>\n<td style=\"padding:12px 16px;color:#374151\">HCPCS Level II J-code (injectable drug)<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Medicare coverage<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Medicare Part B<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Reimbursement basis<\/td>\n<td style=\"padding:12px 16px;color:#374151\">ASP + 6% (non-facility); OPPS for hospital outpatient<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">NDC required<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Yes (Medicare), 5-4-2 format with N4 qualifier<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\">Alteplase is a high-alert medication. According to the <a href=\"https:\/\/www.aapc.com\/codes\/hcpcs-codes-range\/\" target=\"_blank\" rel=\"nofollow noopener\">AAPC&#8217;s HCPCS code reference<\/a>, J2997 falls under the J0000-J8999 injectable drug range. Coders must verify the current CMS HCPCS Level II annual file to confirm any descriptor or coverage changes, because HCPCS codes are updated each January.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Clinical indications and covered diagnoses<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Alteplase is FDA-approved for three primary indications: acute ischemic stroke, acute myocardial infarction (AMI), and pulmonary embolism (PE). Medicare covers J2997 when the administered drug is medically necessary and the supporting diagnosis code maps to a covered indication. Facilities that also provide IV vitamin therapy alongside thrombolytics should document the clinical indication explicitly before submitting a claim.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Many AMI patients return afterward for secondary-prevention counseling.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Beyond these three approved indications, catheter occlusion clearance is not an off-label use. Cathflo Activase, a 2 mg alteplase formulation, carries its own FDA approval for restoring function to central venous access devices blocked by a clot, separate from the three indications above for full-dose Activase.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Billers should still confirm the applicable Local Coverage Determination (LCD) from their Medicare Administrative Contractor (MAC) before billing, since Cathflo claims follow different coding and coverage rules than full-dose thrombolysis claims. True off-label uses of alteplase, such as deep vein thrombosis thrombolysis, may not be covered under standard Medicare policy and should be verified the same way.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Clinical Indication<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">ICD-10-CM Code Range<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Example Codes<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Acute ischemic stroke<\/td>\n<td style=\"padding:12px 16px;color:#374151\">I63.x<\/td>\n<td style=\"padding:12px 16px;color:#374151\">I63.00, I63.10, I63.20, I63.30, I63.50<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Acute myocardial infarction<\/td>\n<td style=\"padding:12px 16px;color:#374151\">I21.x<\/td>\n<td style=\"padding:12px 16px;color:#374151\">I21.01, I21.09, I21.11, I21.19<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Pulmonary embolism<\/td>\n<td style=\"padding:12px 16px;color:#374151\">I26.x<\/td>\n<td style=\"padding:12px 16px;color:#374151\">I26.01, I26.09, I26.90, I26.99<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Deep vein thrombosis <em>(off-label)<\/em><\/td>\n<td style=\"padding:12px 16px;color:#374151\">I82.x<\/td>\n<td style=\"padding:12px 16px;color:#374151\">I82.401, I82.411, I82.491 &mdash; verify MAC\/payer coverage before billing<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\">These ICD-10-CM codes link the clinical necessity of alteplase administration to the HCPCS Code J2997 claim line. The diagnosis code on the claim must match the documented indication in the patient&#8217;s record. Mismatched or unsupported diagnosis codes are among the top denial triggers for this code.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Billers managing mobile IV therapy operations that occasionally administer thrombolytics should ensure their documentation workflow captures the exact indication before claim submission.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Medicare coverage and reimbursement for HCPCS Code J2997<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">HCPCS Code J2997 is a covered Medicare Part B benefit when medically necessary. The reimbursement methodology follows the Average Sales Price (ASP) model, with payment set at ASP + 6% for non-facility settings. In hospital outpatient settings, the code is bundled under the Hospital Outpatient Prospective Payment System (OPPS) and paid at the applicable Ambulatory Payment Classification (APC) rate.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">ASP-based payment amounts change every quarter. The current allowable rate for J2997 must be verified against the <a href=\"https:\/\/www.cms.gov\/medicare\/payment\/part-b-drugs\/asp-pricing-files\" target=\"_blank\" rel=\"nofollow noopener\">CMS ASP Pricing Files<\/a> or the quarterly ASP drug pricing file published by CMS. Never treat a previously calculated rate as permanent. Using an outdated rate for billing purposes can result in underpayment or compliance flags on post-payment audits.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Reviewing EHR integration for billing is also worthwhile here: practices that integrate their EHR with billing software can automatically pull the current ASP quarter and flag unit discrepancies before claims leave the practice.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Coverage setting differences<\/h3>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Setting<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Payment System<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">POS Code<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Notes<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Physician office<\/td>\n<td style=\"padding:12px 16px;color:#374151\">ASP + 6%<\/td>\n<td style=\"padding:12px 16px;color:#374151\">11<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Non-facility rate; drug cost reimbursed separately<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Hospital outpatient<\/td>\n<td style=\"padding:12px 16px;color:#374151\">OPPS \/ APC rate<\/td>\n<td style=\"padding:12px 16px;color:#374151\">22<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Facility bills UB-04; drug bundled in APC payment<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Inpatient hospital<\/td>\n<td style=\"padding:12px 16px;color:#374151\">DRG (Part A)<\/td>\n<td style=\"padding:12px 16px;color:#374151\">21<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Drug cost included in DRG payment; J2997 not separately billable<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\">Prior authorization is generally not required for Medicare fee-for-service claims for J2997, given the acute emergency nature of its indications. However, commercial payer PA requirements vary significantly. Always verify PA status with the individual payer before administration in non-emergency contexts.<\/p>\n\n\n        <div id=\"book_a_demo\">\n            <div class=\"left-side\">\n                <div class=\"logo\">\n                    <img decoding=\"async\"\n                        src=\"https:\/\/pabau.com\/wp-content\/uploads\/2026\/01\/Logo.svg\"\n                        alt=\"Logo\"\n                        loading=\"lazy\"\n                    \/>\n                <\/div>\n\n                <h3 class=\"heading\">\n                    Reduce claim denials on high-cost drug codes                <\/h3>\n\n                <p class=\"description\">\n                    Pabau&#8217;s claims management software helps billing teams track drug units, attach the right modifiers, and validate NDC fields before claims leave the practice. See how it works for injection billing.                <\/p>\n\n                <div class=\"button-group\">\n                    <a href=\"\/book-demo\/\" class=\"btn btn-scale-effect btn-cta-color btn-md\">\n                        <span class=\"btn-text\">Book a demo<\/span>\n                        <div class=\"btn-icon btn-icon-right\" aria-hidden=\"true\">\n                            <svg\n                                width=\"14\"\n                                height=\"12\"\n                                viewBox=\"0 0 14 12\"\n                                fill=\"none\"\n                                xmlns=\"http:\/\/www.w3.org\/2000\/svg\"\n                            >\n                                <path\n                                    d=\"M0.75 4.77295C0.335786 4.77295 0 5.10874 0 5.52295C0 5.93716 0.335786 6.27295 0.75 6.27295V5.52295V4.77295ZM13.2803 6.05328C13.5732 5.76039 13.5732 5.28551 13.2803 4.99262L8.50736 0.219648C8.21447 -0.073245 7.73959 -0.073245 7.4467 0.219648C7.15381 0.512542 7.15381 0.987415 7.4467 1.28031L11.6893 5.52295L7.4467 9.76559C7.15381 10.0585 7.15381 10.5334 7.4467 10.8263C7.73959 11.1191 8.21447 11.1191 8.50736 10.8263L13.2803 6.05328ZM0.75 5.52295V6.27295L12.75 6.27295V5.52295V4.77295L0.75 4.77295V5.52295Z\"\n                                    fill=\"currentColor\"\n                                ><\/path>\n                            <\/svg>\n                        <\/div>\n                    <\/a>\n                <\/div>\n            <\/div>\n\n            <div class=\"right-side\">\n                <img decoding=\"async\"\n                    src=\"https:\/\/pabau.com\/wp-content\/uploads\/2026\/01\/Home-Page-Concept-4.webp\"\n                    alt=\"Pabau claims management dashboard\"\n                    loading=\"lazy\"\n                \/>\n            <\/div>\n        <\/div>\n        \n\n\n<h2 class=\"wp-block-heading\">How to bill J2997: step-by-step<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Submitting HCPCS Code J2997 accurately requires attention to four claim elements: units, NDC, modifiers, and diagnosis linkage. Miss any one and the claim denies. Here is the submission sequence for a standard Medicare Part B claim using the CMS-1500 form.<\/p>\n\n\n\n<ol class=\"wp-block-list\"><li><strong>Determine units administered.<\/strong> Count the exact milligrams of alteplase administered. Each 1 mg = 1 unit on the claim. A patient receiving 50 mg requires 50 units billed on the J2997 line.<\/li><li><strong>Record the National Drug Code (NDC).<\/strong> Identify the NDC from the product label or vial. Format: 5-4-2 with leading zeros preserved. Add qualifier N4 before the NDC in the appropriate claim field (Box 24 on CMS-1500 or the equivalent electronic 837P segment).<\/li><li><strong>Attach the correct modifier(s).<\/strong> Append modifier JA for intravenous administration (most common for alteplase). If drug from a single-dose vial is discarded, append modifier JW on a separate line to report the wasted amount.<\/li><li><strong>Link the supporting ICD-10-CM diagnosis code.<\/strong> Use the diagnosis pointer in Box 24E to connect the J2997 line to the applicable condition code (e.g. I63.x for ischemic stroke).<\/li><li><strong>Report the place of service (POS) code.<\/strong> Use POS 11 for physician office. Hospital outpatient claims go through the UB-04 form with POS 22.<\/li><li><strong>Verify against the current ASP quarter.<\/strong> Cross-check the expected reimbursement against the current CMS ASP pricing file before submission. Flag any line where calculated reimbursement falls outside expected range.<\/li><\/ol>\n\n\n\n<p class=\"wp-block-paragraph\">Practices using dedicated claims management software can automate steps 3, 4, and 6 through built-in modifier rules and real-time fee schedule integration. Facilities managing IV therapy billing workflows benefit from software that validates NDC format before a claim reaches the clearinghouse.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.pabau.com\/cdn\/attachments\/pulse\/content-engine\/billing_codes\/hcpcs-code-j2997\/automate-claims-through-healthcode.webp\" alt=\"Automate claims and billing with Pabau\"\/><figcaption class=\"wp-element-caption\"><em>Automate claims and billing with Pabau<\/em><\/figcaption><\/figure>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n\n\n<h3 class=\"wp-block-heading\">Required modifiers for J2997<\/h3>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Modifier<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Description<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">When to Use<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">JA<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Administered intravenously<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Standard IV push or infusion of alteplase<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">JW<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Drug amount discarded\/not administered<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Wasted drug from single-dose vials; separate claim line<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">JZ<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Zero drug wastage (no drug discarded)<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Required since 2023 when no drug is wasted from single-dose vial<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">59<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Distinct procedural service<\/td>\n<td style=\"padding:12px 16px;color:#374151\">When J2997 is billed alongside other drug lines on the same date<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\">Verify all modifier requirements against your MAC&#8217;s current LCD and applicable CMS transmittals. Modifier JZ, introduced in 2023, made wastage reporting mandatory for single-dose vials even when no drug is discarded, so billers must choose between JW and JZ on every applicable J2997 claim line.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Common billing errors and denial reasons for J2997<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Most J2997 denials trace back to five preventable errors. Understanding them before submission is far cheaper than working a denial after the fact.<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li><strong>Incorrect unit count:<\/strong> billing 1 unit for a 50 mg dose is the single most common J2997 error. Units must equal the milligrams administered, not the number of vials opened.<\/li><li><strong>Missing or malformatted NDC:<\/strong> Medicare requires the NDC on every drug claim. A missing N4 qualifier or truncated NDC (missing leading zeros) triggers an automatic denial. Use digital clinical forms that prompt staff to record the NDC at the point of administration.<\/li><li><strong>Mismatched diagnosis code:<\/strong> the ICD-10-CM code in Box 21 must support the clinical necessity of alteplase. An unspecified cardiovascular code without specificity (e.g. I99.9) will not link adequately to J2997.<\/li><li><strong>Missing JW\/JZ modifier:<\/strong> since 2023, claims from single-dose vials require one of these modifiers. Omitting both results in a claim edit.<\/li><li><strong>Wrong place of service:<\/strong> billing with POS 11 when the administration occurred in a hospital outpatient department (POS 22) routes the claim to the wrong payment system and causes rejection.<\/li><\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Billers should also review HIPAA compliance in billing workflows when storing alteplase administration records electronically, particularly for facilities that digitise vial lot numbers and administration timestamps alongside claim data.<\/p>\n\n\n        <div id=\"pro_tip\">\n            <div class=\"img\">\n                <svg width=\"42\" height=\"42\" viewBox=\"0 0 42 42\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                    <path fill-rule=\"evenodd\" clip-rule=\"evenodd\"\n                        d=\"M12.6383 19.5238C12.6632 21.2071 12.8734 22.9926 12.0685 24.5523C11.0341 26.8917 8.45076 28.169 7.56292 30.5918C6.63082 33.1061 7.19505 36.185 9.31371 37.9786C10.929 39.5678 13.4183 39.9873 15.6061 39.5463C17.4592 39.073 19.1049 37.8388 19.9706 36.1608C20.781 34.7141 20.7866 32.9904 20.5293 31.3985C20.1006 29.3092 18.3775 27.8705 16.9807 26.362C14.8814 24.1005 14.6684 20.6854 15.595 17.8915C16.4331 15.4768 19.0026 14.2344 20.0425 11.9461C20.7202 10.6769 20.7506 9.20327 20.6068 7.81304C20.1864 5.40098 18.3139 3.23631 15.8716 2.56674C13.9742 2.03969 11.8224 2.30052 10.1739 3.37614C8.70522 4.34688 7.5878 5.86618 7.28356 7.58178C6.76081 9.82981 7.53525 12.2822 9.20307 13.9118C10.7658 15.4741 12.4806 17.2273 12.6383 19.5238Z\"\n                        fill=\"#2BADD4\" \/>\n                    <path fill-rule=\"evenodd\" clip-rule=\"evenodd\"\n                        d=\"M22.7048 19.8387C22.6822 22.3279 24.4507 24.6234 26.7493 25.4682C28.0531 25.961 29.4725 25.9183 30.7989 25.5487C32.0575 24.9955 33.301 24.2237 34.0069 23.0092C34.8384 21.5811 35.2982 19.8286 34.7832 18.2094C34.3611 16.2507 32.8739 14.6541 31.0275 13.9426C28.6736 12.9595 25.8073 13.7942 24.1719 15.7001C23.2022 16.8366 22.6143 18.3326 22.7048 19.8387Z\"\n                        fill=\"#2BADD4\" \/>\n                <\/svg>\n            <\/div>\n            <div class=\"text\">\n                <h3>Pro Tip<\/h3>\n                <p>Run a pre-submission audit on every J2997 claim: verify units match mg administered, NDC uses the 5-4-2 format with N4 qualifier, the JW or JZ modifier is present, and the diagnosis pointer links to an active I21.x, I26.x, or I63.x code. Catching these four items before submission eliminates over 80% of common J2997 denial reasons.<\/p>\n            <\/div>\n        <\/div>\n    \n\n\n<h2 class=\"wp-block-heading\">J2997 vs related thrombolytic drug codes<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Alteplase is not the only thrombolytic billed with a J-code. The table below maps the key thrombolytic HCPCS codes so billers can confirm they are using the right one before submitting a claim.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">HCPCS Code<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Drug Name<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Unit<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Key Distinction<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">J2997<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Alteplase recombinant (Activase)<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Per 1 mg<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Full-dose alteplase; stroke, AMI, PE<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">J2995<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Streptokinase<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Per 250,000 IU<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Older thrombolytic; rarely used since tPA availability<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">J3364<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Urokinase<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Per 5,000 IU vial<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Catheter clearance and PE; different mechanism from tPA<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">J3101<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Tenecteplase (TNKase)<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Per 1 mg<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Single-bolus AMI thrombolytic; do not substitute for J2997<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">J2997<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Alteplase recombinant (Cathflo)<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Per 1 mg<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Same code used for Cathflo formulation (catheter clearance); verify MAC LCD for coverage<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\">Using J3101 (tenecteplase) when alteplase was administered, or vice versa, results in a payment mismatch and a likely audit flag. These are distinct drugs with different ASP rates and different FDA-approved indications. Always cross-reference the product label with the HCPCS code descriptor before billing.<\/p>\n\n\n        <div id=\"pro_tip\">\n            <div class=\"img\">\n                <svg width=\"42\" height=\"42\" viewBox=\"0 0 42 42\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                    <path fill-rule=\"evenodd\" clip-rule=\"evenodd\"\n                        d=\"M12.6383 19.5238C12.6632 21.2071 12.8734 22.9926 12.0685 24.5523C11.0341 26.8917 8.45076 28.169 7.56292 30.5918C6.63082 33.1061 7.19505 36.185 9.31371 37.9786C10.929 39.5678 13.4183 39.9873 15.6061 39.5463C17.4592 39.073 19.1049 37.8388 19.9706 36.1608C20.781 34.7141 20.7866 32.9904 20.5293 31.3985C20.1006 29.3092 18.3775 27.8705 16.9807 26.362C14.8814 24.1005 14.6684 20.6854 15.595 17.8915C16.4331 15.4768 19.0026 14.2344 20.0425 11.9461C20.7202 10.6769 20.7506 9.20327 20.6068 7.81304C20.1864 5.40098 18.3139 3.23631 15.8716 2.56674C13.9742 2.03969 11.8224 2.30052 10.1739 3.37614C8.70522 4.34688 7.5878 5.86618 7.28356 7.58178C6.76081 9.82981 7.53525 12.2822 9.20307 13.9118C10.7658 15.4741 12.4806 17.2273 12.6383 19.5238Z\"\n                        fill=\"#2BADD4\" \/>\n                    <path fill-rule=\"evenodd\" clip-rule=\"evenodd\"\n                        d=\"M22.7048 19.8387C22.6822 22.3279 24.4507 24.6234 26.7493 25.4682C28.0531 25.961 29.4725 25.9183 30.7989 25.5487C32.0575 24.9955 33.301 24.2237 34.0069 23.0092C34.8384 21.5811 35.2982 19.8286 34.7832 18.2094C34.3611 16.2507 32.8739 14.6541 31.0275 13.9426C28.6736 12.9595 25.8073 13.7942 24.1719 15.7001C23.2022 16.8366 22.6143 18.3326 22.7048 19.8387Z\"\n                        fill=\"#2BADD4\" \/>\n                <\/svg>\n            <\/div>\n            <div class=\"text\">\n                <h3>Pro Tip<\/h3>\n                <p>Verify the exact alteplase product administered before billing J2997. Activase (full-dose) and Cathflo Activase (catheter clearance, 2 mg vial) are both alteplase and both billed with J2997, but their covered indications and NDC numbers differ. Billing the wrong indication for the product used is a common audit trigger.<\/p>\n            <\/div>\n        <\/div>\n    \n\n\n<h2 class=\"wp-block-heading\">Documentation requirements for J2997 claims<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Every J2997 claim submitted to Medicare requires supporting documentation that can withstand a post-payment audit or Additional Documentation Request (ADR). Incomplete records are the root cause of most recovered overpayments on drug claims.<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li><strong>Physician order:<\/strong> a signed order specifying the drug, dose, route of administration, and clinical indication<\/li><li><strong>Administration record:<\/strong> nursing or clinical note documenting the actual mg administered, time, and route<\/li><li><strong>NDC information:<\/strong> vial lot number, NDC, and expiration date from the product label or pharmacy record<\/li><li><strong>Diagnosis linkage:<\/strong> the patient record must clearly support the ICD-10-CM code(s) reported on the claim<\/li><li><strong>Wastage documentation:<\/strong> if modifier JW is used, the record must show the number of mg discarded from the vial<\/li><li><strong>Prior authorization (commercial payers):<\/strong> for non-Medicare claims, include the PA number in the appropriate claim field<\/li><\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Practices using EMR for IV therapy that includes structured drug administration logs catch missing documentation before it reaches a claim. When the administration record, NDC capture, and diagnosis linkage are part of the same clinical workflow rather than separate manual steps, audit exposure shrinks.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pair this with prescription management software to keep medication records audit-ready and timestamped at the point of care.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.pabau.com\/cdn\/attachments\/pulse\/content-engine\/billing_codes\/hcpcs-code-j2997\/end-the-paper-chase-and-delight-patients-with-modern-convenience.webp\" alt=\"End the paper chase and delight patients with modern convenience\"\/><figcaption class=\"wp-element-caption\"><em>End the paper chase and delight patients with modern convenience<\/em><\/figcaption><\/figure>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n\n\n<p class=\"wp-block-paragraph\">For practices still building their documentation templates. Use the <a href=\"https:\/\/www.pgmbilling.com\/hcpcs-lookup-tool\/\" target=\"_blank\" rel=\"nofollow noopener\">PGM Billing HCPCS lookup<\/a> to cross-check the current J2997 descriptor and verify no descriptor revisions have been issued since your last billing update.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Related HCPCS codes<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/pabau.com\/procedure-codes\/hcpcs-code-j7030-normal-saline-infusion\/\">HCPCS code J7030 \u2014 Normal Saline Infusion<\/a><\/li>\n\n\n<li><a href=\"https:\/\/pabau.com\/procedure-codes\/hcpcs-code-j3010-fentanyl-citrate-injection-01-mg\/\">HCPCS code J3010 \u2014 Fentanyl Citrate Injection<\/a><\/li>\n\n\n<li><a href=\"https:\/\/pabau.com\/procedure-codes\/hcpcs-code-j3032-eptinezumab-jjmr-injection-1-mg\/\">HCPCS code J3032 \u2014 Eptinezumab-jjmr Injection<\/a><\/li>\n\n\n<li><a href=\"https:\/\/pabau.com\/procedure-codes\/hcpcs-code-j3111\/\">HCPCS code J3111 \u2014 Injection, romosozumab-aqqg<\/a><\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Conclusion<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Most J2997 claim failures come from the same small set of errors: wrong unit count, missing NDC, mismatched diagnosis, and omitted JW\/JZ modifier. Getting these right on the first submission protects revenue and keeps alteplase claims off the audit radar.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pabau&#8217;s claims management software helps billing teams build pre-submission checklists directly into their drug-billing workflow, so J2997 and similar high-value injection codes are validated before they reach the clearinghouse. To see how it works for your practice, <a href=\"https:\/\/pabau.com\/book-demo\/\">book a demo<\/a>.<\/p>\n\n\n        <div id=\"expert_picks\">\n            <div class=\"header\">\n                                    <img decoding=\"async\" src=\"https:\/\/pabau.com\/wp-content\/uploads\/2025\/11\/Expert-Picks.svg\" alt=\"Continue your research\" height=\"42\" width=\"42\">\n                                <h3>Continue your research<\/h3>\n            <\/div>\n            <div class=\"content\">\n                                                            <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#54B2D3\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p><strong>Need a documentation template for IV drug administration?<\/strong> <a href=\"https:\/\/pabau.com\/templates\/new-client-intake-form-template\/\">new client intake form<\/a> covers the essential fields for capturing clinical necessity before administration.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#54B2D3\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p><strong>Need the billing guide for the IV push itself?<\/strong> <a href=\"https:\/\/pabau.com\/procedure-codes\/cpt-code-96374\/\">96374<\/a> covers the push administration technique used for many alteplase doses.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#54B2D3\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p><strong>Billing a home health visit around the same infusion?<\/strong> <a href=\"https:\/\/pabau.com\/procedure-codes\/hcpcs-code-g0180\/\">G0180<\/a> covers the physician certification that often accompanies home-administered thrombolytic claims.<\/p>\n                        <\/div>\n                                                <\/div>\n        <\/div>\n    \n\n\n<h2 class=\"wp-block-heading\">Frequently Asked Questions<\/h2>\n\n\n\n<div class=\"schema-faq wp-block-yoast-faq-block\"><div class=\"schema-faq-section\" id=\"faq-question-1784537526277\"><h3 class=\"schema-faq-question\">What is HCPCS Code J2997?<\/h3> <p class=\"schema-faq-answer\">HCPCS Code J2997 is the Level II drug code for injection, alteplase recombinant, per 1 mg. It is used to bill Medicare Part B and other payers for the administration of alteplase (brand name Activase), a thrombolytic agent used in acute ischemic stroke, acute myocardial infarction, and pulmonary embolism. Each unit billed equals 1 mg administered.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1784537526278\"><h3 class=\"schema-faq-question\">What drug does J2997 represent?<\/h3> <p class=\"schema-faq-answer\">J2997 represents alteplase recombinant, also sold as Activase by Genentech\/Roche. Alteplase is a recombinant tissue plasminogen activator (tPA) that dissolves blood clots by activating plasminogen. Both the full-dose Activase formulation and the Cathflo Activase (catheter clearance) formulation use J2997, but they have different covered indications and NDC numbers.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1784537526279\"><h3 class=\"schema-faq-question\">How is J2997 used for Medicare billing?<\/h3> <p class=\"schema-faq-answer\">J2997 is billed under Medicare Part B at ASP + 6% in the non-facility setting. To bill correctly, report units equal to the milligrams administered, include the NDC in 5-4-2 format with the N4 qualifier, append modifier JA for IV administration, and link to an appropriate ICD-10-CM diagnosis code. Claims submitted to hospital outpatient settings fall under OPPS, not the Physician Fee Schedule.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1784537526280\"><h3 class=\"schema-faq-question\">What modifiers are used with J2997?<\/h3> <p class=\"schema-faq-answer\">The most common modifier for J2997 is JA (administered intravenously). When drug is wasted from a single-dose vial, modifier JW is required on a separate line to report the discarded amount. If no drug is wasted, modifier JZ must be appended instead (required since 2023). Modifier 59 may be needed when J2997 is billed alongside other drug lines on the same date of service.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1784537526281\"><h3 class=\"schema-faq-question\">What is the difference between J2997 and J3101?<\/h3> <p class=\"schema-faq-answer\">J2997 covers alteplase recombinant (Activase\/tPA), billed per 1 mg. J3101 covers tenecteplase (TNKase), a different thrombolytic billed per 1 mg. These are distinct drugs with different FDA-approved indications, different ASP rates, and different NDC numbers. Billing J3101 when alteplase was administered, or vice versa, constitutes a coding error and can trigger post-payment audits.<\/p> <\/div> <\/div>\n","protected":false},"excerpt":{"rendered":"<p>HCPCS Code J2997 covers injection, alteplase recombinant, per 1 mg, and it sits in the J-series of HCPCS Level II codes maintained by the Centers for Medicare and Medicaid Services (CMS). Getting the units, modifiers, and diagnosis codes right on every claim matters. This guide covers everything billers and coders need to submit accurate IV [&hellip;]<\/p>\n","protected":false},"author":77,"featured_media":159075,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_yoast_wpseo_linkdex":"86","_yoast_wpseo_content_score":"60","_yoast_wpseo_is_cornerstone":"","_yoast_wpseo_keywordsynonyms":"[\"\",\"\",\"\",\"\"]","_yoast_wpseo_focuskw_text_input":"","_seo_original_html":"","footnotes":""},"categories":[1433,1548],"tags":[],"class_list":["post-159076","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-billing-codes","category-hcpcs"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.2 (Yoast SEO v28.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>HCPCS Code J2997 for Alteplase: Key Insights<\/title>\n<meta name=\"description\" content=\"HCPCS Code J2997 covers alteplase injection billed per 1 mg, reimbursed at ASP + 6% under Medicare Part B, with mandatory NDC reporting.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pabau.com\/es\/procedure-codes\/hcpcs-code-j2997\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"HCPCS Code J2997 for Alteplase: Key Insights\" \/>\n<meta property=\"og:description\" content=\"HCPCS Code J2997 covers alteplase injection billed per 1 mg, reimbursed at ASP + 6% under Medicare Part B, with mandatory NDC reporting.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pabau.com\/es\/procedure-codes\/hcpcs-code-j2997\/\" \/>\n<meta property=\"og:site_name\" content=\"Pabau\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Pabau\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-20T10:19:03+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-13T12:11:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/pabau.com\/wp-content\/uploads\/2026\/07\/hcpcs-code-j2997.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Katy Piper\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@pabaucrm\" \/>\n<meta name=\"twitter:site\" content=\"@pabaucrm\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Katy Piper\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"11 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/procedure-codes\\\/hcpcs-code-j2997\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/procedure-codes\\\/hcpcs-code-j2997\\\/\"},\"author\":{\"name\":\"Katy Piper\",\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/#\\\/schema\\\/person\\\/5de22f4ff3ec59b1925ef02dce956d7d\"},\"headline\":\"HCPCS Code J2997: Alteplase billing, coverage, and reimbursement\",\"datePublished\":\"2026-07-20T10:19:03+00:00\",\"dateModified\":\"2026-08-13T12:11:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/procedure-codes\\\/hcpcs-code-j2997\\\/\"},\"wordCount\":2190,\"publisher\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/procedure-codes\\\/hcpcs-code-j2997\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/hcpcs-code-j2997.webp\",\"articleSection\":[\"Billing Codes\",\"HCPCS\"],\"inLanguage\":\"es\"},{\"@type\":[\"WebPage\",\"FAQPage\"],\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/procedure-codes\\\/hcpcs-code-j2997\\\/\",\"url\":\"https:\\\/\\\/pabau.com\\\/es\\\/procedure-codes\\\/hcpcs-code-j2997\\\/\",\"name\":\"HCPCS Code J2997 for Alteplase: Key Insights\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/procedure-codes\\\/hcpcs-code-j2997\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/procedure-codes\\\/hcpcs-code-j2997\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/hcpcs-code-j2997.webp\",\"datePublished\":\"2026-07-20T10:19:03+00:00\",\"dateModified\":\"2026-08-13T12:11:29+00:00\",\"description\":\"HCPCS Code J2997 covers alteplase injection billed per 1 mg, reimbursed at ASP + 6% under Medicare Part B, with mandatory NDC reporting.\",\"mainEntity\":[{\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/procedure-codes\\\/hcpcs-code-j2997\\\/#faq-question-1784537526277\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/procedure-codes\\\/hcpcs-code-j2997\\\/#faq-question-1784537526278\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/procedure-codes\\\/hcpcs-code-j2997\\\/#faq-question-1784537526279\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/procedure-codes\\\/hcpcs-code-j2997\\\/#faq-question-1784537526280\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/procedure-codes\\\/hcpcs-code-j2997\\\/#faq-question-1784537526281\"}],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pabau.com\\\/es\\\/procedure-codes\\\/hcpcs-code-j2997\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/procedure-codes\\\/hcpcs-code-j2997\\\/#primaryimage\",\"url\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/hcpcs-code-j2997.webp\",\"contentUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/hcpcs-code-j2997.webp\",\"width\":1200,\"height\":630},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/pabau.com\\\/es\\\/\",\"name\":\"Pabau\",\"description\":\"Clinic Software for your Business | Go Paperless Today\",\"publisher\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pabau.com\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/#organization\",\"name\":\"Pabau\",\"url\":\"https:\\\/\\\/pabau.com\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/Logo-4-e1654525062364.png\",\"contentUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/Logo-4-e1654525062364.png\",\"width\":736,\"height\":195,\"caption\":\"Pabau\"},\"image\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/Pabau\\\/\",\"https:\\\/\\\/x.com\\\/pabaucrm\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/pabau-ltd\\\/\",\"https:\\\/\\\/www.instagram.com\\\/pabausoftware\\\/\"],\"description\":\"Pabau is an all-in-one healthcare practice management software platform designed for clinics, medspas, therapists, and medical professionals. It combines scheduling, electronic health records, clinical forms, payments, marketing automation, reporting, and patient engagement tools into one secure cloud system to help practices streamline operations and grow their business.\",\"foundingDate\":\"2011-10-20\",\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":\"201\",\"maxValue\":\"500\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/#\\\/schema\\\/person\\\/5de22f4ff3ec59b1925ef02dce956d7d\",\"name\":\"Katy Piper\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/cropped-Snip20260306_177-96x96.png\",\"url\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/cropped-Snip20260306_177-96x96.png\",\"contentUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/cropped-Snip20260306_177-96x96.png\",\"caption\":\"Katy Piper\"},\"description\":\"Katy Piper is a content writer covering aesthetics, dermatology, and clinic operations, with a knack for making clinical detail feel approachable. Outside of work, she's usually chasing her border collie around muddy fields or hunting down the best flat white in town.\",\"url\":\"https:\\\/\\\/pabau.com\\\/es\\\/blog\\\/author\\\/katy-piper\\\/\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/procedure-codes\\\/hcpcs-code-j2997\\\/#faq-question-1784537526277\",\"position\":1,\"url\":\"https:\\\/\\\/pabau.com\\\/es\\\/procedure-codes\\\/hcpcs-code-j2997\\\/#faq-question-1784537526277\",\"name\":\"What is HCPCS Code J2997?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"HCPCS Code J2997 is the Level II drug code for injection, alteplase recombinant, per 1 mg. It is used to bill Medicare Part B and other payers for the administration of alteplase (brand name Activase), a thrombolytic agent used in acute ischemic stroke, acute myocardial infarction, and pulmonary embolism. Each unit billed equals 1 mg administered.\",\"inLanguage\":\"es\"},\"inLanguage\":\"es\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/procedure-codes\\\/hcpcs-code-j2997\\\/#faq-question-1784537526278\",\"position\":2,\"url\":\"https:\\\/\\\/pabau.com\\\/es\\\/procedure-codes\\\/hcpcs-code-j2997\\\/#faq-question-1784537526278\",\"name\":\"What drug does J2997 represent?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"J2997 represents alteplase recombinant, also sold as Activase by Genentech\\\/Roche. Alteplase is a recombinant tissue plasminogen activator (tPA) that dissolves blood clots by activating plasminogen. Both the full-dose Activase formulation and the Cathflo Activase (catheter clearance) formulation use J2997, but they have different covered indications and NDC numbers.\",\"inLanguage\":\"es\"},\"inLanguage\":\"es\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/procedure-codes\\\/hcpcs-code-j2997\\\/#faq-question-1784537526279\",\"position\":3,\"url\":\"https:\\\/\\\/pabau.com\\\/es\\\/procedure-codes\\\/hcpcs-code-j2997\\\/#faq-question-1784537526279\",\"name\":\"How is J2997 used for Medicare billing?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"J2997 is billed under Medicare Part B at ASP + 6% in the non-facility setting. To bill correctly, report units equal to the milligrams administered, include the NDC in 5-4-2 format with the N4 qualifier, append modifier JA for IV administration, and link to an appropriate ICD-10-CM diagnosis code. Claims submitted to hospital outpatient settings fall under OPPS, not the Physician Fee Schedule.\",\"inLanguage\":\"es\"},\"inLanguage\":\"es\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/procedure-codes\\\/hcpcs-code-j2997\\\/#faq-question-1784537526280\",\"position\":4,\"url\":\"https:\\\/\\\/pabau.com\\\/es\\\/procedure-codes\\\/hcpcs-code-j2997\\\/#faq-question-1784537526280\",\"name\":\"What modifiers are used with J2997?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The most common modifier for J2997 is JA (administered intravenously). When drug is wasted from a single-dose vial, modifier JW is required on a separate line to report the discarded amount. If no drug is wasted, modifier JZ must be appended instead (required since 2023). Modifier 59 may be needed when J2997 is billed alongside other drug lines on the same date of service.\",\"inLanguage\":\"es\"},\"inLanguage\":\"es\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/es\\\/procedure-codes\\\/hcpcs-code-j2997\\\/#faq-question-1784537526281\",\"position\":5,\"url\":\"https:\\\/\\\/pabau.com\\\/es\\\/procedure-codes\\\/hcpcs-code-j2997\\\/#faq-question-1784537526281\",\"name\":\"What is the difference between J2997 and J3101?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"J2997 covers alteplase recombinant (Activase\\\/tPA), billed per 1 mg. J3101 covers tenecteplase (TNKase), a different thrombolytic billed per 1 mg. These are distinct drugs with different FDA-approved indications, different ASP rates, and different NDC numbers. Billing J3101 when alteplase was administered, or vice versa, constitutes a coding error and can trigger post-payment audits.\",\"inLanguage\":\"es\"},\"inLanguage\":\"es\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"HCPCS Code J2997 for Alteplase: Key Insights","description":"HCPCS Code J2997 covers alteplase injection billed per 1 mg, reimbursed at ASP + 6% under Medicare Part B, with mandatory NDC reporting.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pabau.com\/es\/procedure-codes\/hcpcs-code-j2997\/","og_locale":"es_ES","og_type":"article","og_title":"HCPCS Code J2997 for Alteplase: Key Insights","og_description":"HCPCS Code J2997 covers alteplase injection billed per 1 mg, reimbursed at ASP + 6% under Medicare Part B, with mandatory NDC reporting.","og_url":"https:\/\/pabau.com\/es\/procedure-codes\/hcpcs-code-j2997\/","og_site_name":"Pabau","article_publisher":"https:\/\/www.facebook.com\/Pabau\/","article_published_time":"2026-07-20T10:19:03+00:00","article_modified_time":"2026-08-13T12:11:29+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/07\/hcpcs-code-j2997.webp","type":"image\/webp"}],"author":"Katy Piper","twitter_card":"summary_large_image","twitter_creator":"@pabaucrm","twitter_site":"@pabaucrm","twitter_misc":{"Escrito por":"Katy Piper","Tiempo de lectura":"11 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pabau.com\/es\/procedure-codes\/hcpcs-code-j2997\/#article","isPartOf":{"@id":"https:\/\/pabau.com\/es\/procedure-codes\/hcpcs-code-j2997\/"},"author":{"name":"Katy Piper","@id":"https:\/\/pabau.com\/es\/#\/schema\/person\/5de22f4ff3ec59b1925ef02dce956d7d"},"headline":"HCPCS Code J2997: Alteplase billing, coverage, and reimbursement","datePublished":"2026-07-20T10:19:03+00:00","dateModified":"2026-08-13T12:11:29+00:00","mainEntityOfPage":{"@id":"https:\/\/pabau.com\/es\/procedure-codes\/hcpcs-code-j2997\/"},"wordCount":2190,"publisher":{"@id":"https:\/\/pabau.com\/es\/#organization"},"image":{"@id":"https:\/\/pabau.com\/es\/procedure-codes\/hcpcs-code-j2997\/#primaryimage"},"thumbnailUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/07\/hcpcs-code-j2997.webp","articleSection":["Billing Codes","HCPCS"],"inLanguage":"es"},{"@type":["WebPage","FAQPage"],"@id":"https:\/\/pabau.com\/es\/procedure-codes\/hcpcs-code-j2997\/","url":"https:\/\/pabau.com\/es\/procedure-codes\/hcpcs-code-j2997\/","name":"HCPCS Code J2997 for Alteplase: Key Insights","isPartOf":{"@id":"https:\/\/pabau.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pabau.com\/es\/procedure-codes\/hcpcs-code-j2997\/#primaryimage"},"image":{"@id":"https:\/\/pabau.com\/es\/procedure-codes\/hcpcs-code-j2997\/#primaryimage"},"thumbnailUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/07\/hcpcs-code-j2997.webp","datePublished":"2026-07-20T10:19:03+00:00","dateModified":"2026-08-13T12:11:29+00:00","description":"HCPCS Code J2997 covers alteplase injection billed per 1 mg, reimbursed at ASP + 6% under Medicare Part B, with mandatory NDC reporting.","mainEntity":[{"@id":"https:\/\/pabau.com\/es\/procedure-codes\/hcpcs-code-j2997\/#faq-question-1784537526277"},{"@id":"https:\/\/pabau.com\/es\/procedure-codes\/hcpcs-code-j2997\/#faq-question-1784537526278"},{"@id":"https:\/\/pabau.com\/es\/procedure-codes\/hcpcs-code-j2997\/#faq-question-1784537526279"},{"@id":"https:\/\/pabau.com\/es\/procedure-codes\/hcpcs-code-j2997\/#faq-question-1784537526280"},{"@id":"https:\/\/pabau.com\/es\/procedure-codes\/hcpcs-code-j2997\/#faq-question-1784537526281"}],"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pabau.com\/es\/procedure-codes\/hcpcs-code-j2997\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/pabau.com\/es\/procedure-codes\/hcpcs-code-j2997\/#primaryimage","url":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/07\/hcpcs-code-j2997.webp","contentUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/07\/hcpcs-code-j2997.webp","width":1200,"height":630},{"@type":"WebSite","@id":"https:\/\/pabau.com\/es\/#website","url":"https:\/\/pabau.com\/es\/","name":"Pabau","description":"Clinic Software for your Business | Go Paperless Today","publisher":{"@id":"https:\/\/pabau.com\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pabau.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/pabau.com\/es\/#organization","name":"Pabau","url":"https:\/\/pabau.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/pabau.com\/es\/#\/schema\/logo\/image\/","url":"https:\/\/pabau.com\/wp-content\/uploads\/2022\/05\/Logo-4-e1654525062364.png","contentUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2022\/05\/Logo-4-e1654525062364.png","width":736,"height":195,"caption":"Pabau"},"image":{"@id":"https:\/\/pabau.com\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Pabau\/","https:\/\/x.com\/pabaucrm","https:\/\/www.linkedin.com\/company\/pabau-ltd\/","https:\/\/www.instagram.com\/pabausoftware\/"],"description":"Pabau is an all-in-one healthcare practice management software platform designed for clinics, medspas, therapists, and medical professionals. It combines scheduling, electronic health records, clinical forms, payments, marketing automation, reporting, and patient engagement tools into one secure cloud system to help practices streamline operations and grow their business.","foundingDate":"2011-10-20","numberOfEmployees":{"@type":"QuantitativeValue","minValue":"201","maxValue":"500"}},{"@type":"Person","@id":"https:\/\/pabau.com\/es\/#\/schema\/person\/5de22f4ff3ec59b1925ef02dce956d7d","name":"Katy Piper","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/03\/cropped-Snip20260306_177-96x96.png","url":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/03\/cropped-Snip20260306_177-96x96.png","contentUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/03\/cropped-Snip20260306_177-96x96.png","caption":"Katy Piper"},"description":"Katy Piper is a content writer covering aesthetics, dermatology, and clinic operations, with a knack for making clinical detail feel approachable. Outside of work, she's usually chasing her border collie around muddy fields or hunting down the best flat white in town.","url":"https:\/\/pabau.com\/es\/blog\/author\/katy-piper\/"},{"@type":"Question","@id":"https:\/\/pabau.com\/es\/procedure-codes\/hcpcs-code-j2997\/#faq-question-1784537526277","position":1,"url":"https:\/\/pabau.com\/es\/procedure-codes\/hcpcs-code-j2997\/#faq-question-1784537526277","name":"What is HCPCS Code J2997?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"HCPCS Code J2997 is the Level II drug code for injection, alteplase recombinant, per 1 mg. It is used to bill Medicare Part B and other payers for the administration of alteplase (brand name Activase), a thrombolytic agent used in acute ischemic stroke, acute myocardial infarction, and pulmonary embolism. Each unit billed equals 1 mg administered.","inLanguage":"es"},"inLanguage":"es"},{"@type":"Question","@id":"https:\/\/pabau.com\/es\/procedure-codes\/hcpcs-code-j2997\/#faq-question-1784537526278","position":2,"url":"https:\/\/pabau.com\/es\/procedure-codes\/hcpcs-code-j2997\/#faq-question-1784537526278","name":"What drug does J2997 represent?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"J2997 represents alteplase recombinant, also sold as Activase by Genentech\/Roche. Alteplase is a recombinant tissue plasminogen activator (tPA) that dissolves blood clots by activating plasminogen. Both the full-dose Activase formulation and the Cathflo Activase (catheter clearance) formulation use J2997, but they have different covered indications and NDC numbers.","inLanguage":"es"},"inLanguage":"es"},{"@type":"Question","@id":"https:\/\/pabau.com\/es\/procedure-codes\/hcpcs-code-j2997\/#faq-question-1784537526279","position":3,"url":"https:\/\/pabau.com\/es\/procedure-codes\/hcpcs-code-j2997\/#faq-question-1784537526279","name":"How is J2997 used for Medicare billing?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"J2997 is billed under Medicare Part B at ASP + 6% in the non-facility setting. To bill correctly, report units equal to the milligrams administered, include the NDC in 5-4-2 format with the N4 qualifier, append modifier JA for IV administration, and link to an appropriate ICD-10-CM diagnosis code. Claims submitted to hospital outpatient settings fall under OPPS, not the Physician Fee Schedule.","inLanguage":"es"},"inLanguage":"es"},{"@type":"Question","@id":"https:\/\/pabau.com\/es\/procedure-codes\/hcpcs-code-j2997\/#faq-question-1784537526280","position":4,"url":"https:\/\/pabau.com\/es\/procedure-codes\/hcpcs-code-j2997\/#faq-question-1784537526280","name":"What modifiers are used with J2997?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"The most common modifier for J2997 is JA (administered intravenously). When drug is wasted from a single-dose vial, modifier JW is required on a separate line to report the discarded amount. If no drug is wasted, modifier JZ must be appended instead (required since 2023). Modifier 59 may be needed when J2997 is billed alongside other drug lines on the same date of service.","inLanguage":"es"},"inLanguage":"es"},{"@type":"Question","@id":"https:\/\/pabau.com\/es\/procedure-codes\/hcpcs-code-j2997\/#faq-question-1784537526281","position":5,"url":"https:\/\/pabau.com\/es\/procedure-codes\/hcpcs-code-j2997\/#faq-question-1784537526281","name":"What is the difference between J2997 and J3101?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"J2997 covers alteplase recombinant (Activase\/tPA), billed per 1 mg. J3101 covers tenecteplase (TNKase), a different thrombolytic billed per 1 mg. These are distinct drugs with different FDA-approved indications, different ASP rates, and different NDC numbers. Billing J3101 when alteplase was administered, or vice versa, constitutes a coding error and can trigger post-payment audits.","inLanguage":"es"},"inLanguage":"es"}]}},"yoast":{"focus_keyword":"HCPCS Code J2997","seo_title":"HCPCS Code J2997 for Alteplase: Key Insights","meta_description":"HCPCS Code J2997 covers alteplase injection billed per 1 mg, reimbursed at ASP + 6% under Medicare Part B, with mandatory NDC reporting.","content_score":"60","is_cornerstone":"","related_keyphrases":[{"keyword":"j code hcpcs drug billing","score":56},{"keyword":"hcpcs code lookup","score":61},{"keyword":"medicare part b drug codes","score":61}]},"_links":{"self":[{"href":"https:\/\/pabau.com\/es\/wp-json\/wp\/v2\/posts\/159076","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pabau.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pabau.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pabau.com\/es\/wp-json\/wp\/v2\/users\/77"}],"replies":[{"embeddable":true,"href":"https:\/\/pabau.com\/es\/wp-json\/wp\/v2\/comments?post=159076"}],"version-history":[{"count":5,"href":"https:\/\/pabau.com\/es\/wp-json\/wp\/v2\/posts\/159076\/revisions"}],"predecessor-version":[{"id":179432,"href":"https:\/\/pabau.com\/es\/wp-json\/wp\/v2\/posts\/159076\/revisions\/179432"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pabau.com\/es\/wp-json\/wp\/v2\/media\/159075"}],"wp:attachment":[{"href":"https:\/\/pabau.com\/es\/wp-json\/wp\/v2\/media?parent=159076"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pabau.com\/es\/wp-json\/wp\/v2\/categories?post=159076"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pabau.com\/es\/wp-json\/wp\/v2\/tags?post=159076"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}